Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 6757898, 10 pages
https://doi.org/10.1155/2017/6757898
Clinical Study

Metastasis-Associated Protein 1 Is Involved in Angiogenesis after Transarterial Chemoembolization Treatment

1College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China
2Laboratory of Molecular Medicine, First People’s Hospital Affiliated to Huzhou University, Huzhou 313000, China
3Department of Hepatobiliary Surgery, First People’s Hospital Affiliated to Huzhou University, Huzhou 313000, China
4Department of Nephrology, First People’s Hospital Affiliated to Huzhou University, Huzhou 313000, China
5Moores Cancer Center, University of California, San Diego, CA 92037, USA
6Department of Ultrasound, First People’s Hospital Affiliated to Huzhou University, Huzhou 313000, China
7Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China

Correspondence should be addressed to Jianming Guan; moc.621@0039naug and Suhong Chen; nc.ude.tujz@gnohusnehc

Received 22 December 2016; Accepted 23 March 2017; Published 15 May 2017

Academic Editor: Melchiorre Cervello

Copyright © 2017 Tao Xue et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Llovet, “Updated treatment approach to hepatocellular carcinoma,” Journal of Gastroenterology, vol. 40, no. 3, pp. 225–235, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. P. F. Lalor, P. S. Shields, A. J. Grant, and D. H. Adams, “Recruitment of lymphocytes to the human liver,” Immunology and Cell Biology, vol. 80, no. 1, pp. 52–64, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Breedis and G. Young, “The blood supply of neoplasms in the liver,” The American Journal of Pathology, vol. 30, no. 5, pp. 969–977, 1954. View at Google Scholar · View at Scopus
  4. R. Lencioni and L. Crocetti, “Local-regional treatment of hepatocellular carcinoma,” Radiology, vol. 262, no. 1, pp. 43–58, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Lo, H. Ngan, W. Tso et al., “Randomized controlled trial of transarterial Lipiodol chemoembolization for unresectable hepatocellular carcinoma,” Hepatology, vol. 35, no. 5, pp. 1164–1171, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. F. Yang, R. T.-P. Poon, J. To, D. W. Ho, and S. T. Fan, “The potential role of hypoxia inducible factor 1α in tumor progression after hypoxia and chemotherapy in hepatocellular carcinoma,” Cancer Research, vol. 64, no. 15, pp. 5496–5503, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. Y.-B. Kim, Y. N. Park, and C. Park, “Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolization,” Histopathology, vol. 38, no. 2, pp. 160–166, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Kumar, R. A. Wang, A. Mazumdar et al., “A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm,” Nature, vol. 418, no. 6898, pp. 654–657, 2002. View at Publisher · View at Google Scholar
  9. R. R. Singh and R. Kumar, “MTA family of transcriptional metaregulators in mammary gland morphogenesis and breast cancer,” Journal of Mammary Gland Biology and Neoplasia, vol. 12, no. 2-3, pp. 115–125, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. D.-Q. Li, S. B. Pakala, S. S. Nair, J. Eswaran, and R. Kumar, “Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer,” Cancer Research, vol. 72, no. 2, pp. 387–394, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Kumar, R.-A. Wang, and R. Bagheri-Yarmand, “Emerging roles of MTA Family Members in Human Cancers,” Seminars in Oncology, vol. 30, 16, no. 5, pp. 30–37, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Toh and G. L. Nicolson, “The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications,” Clinical and Experimental Metastasis, vol. 26, no. 3, pp. 215–227, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. G. L. Wang and G. L. Semenza, “General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 9, pp. 4304–4308, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. S. N. Greer, J. L. Metcalf, Y. Wang, and M. Ohh, “The updated biology of hypoxia-inducible factor,” EMBO Journal, vol. 31, no. 11, pp. 2448–2460, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Bruix and M. Sherman, “Management of hepatocellular carcinoma,” Hepatology, vol. 42, no. 5, pp. 1208–1236, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. H. B. Salvesen, S. Das, and L. A. Akslen, “Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis,” Clinical Cancer Research, vol. 6, no. 1, pp. 153–159, 2000. View at Google Scholar · View at Scopus
  17. N. Weidner, J. P. Semple, W. R. Welch, and J. Folkman, “Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma,” The New England Journal of Medicine, vol. 324, no. 1, pp. 1–8, 1991. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Xue, P. Luo, H. Zhu et al., “Oxidative stress is involved in Dasatinib-induced apoptosis in rat primary hepatocytes,” Toxicology and Applied Pharmacology, vol. 261, no. 3, pp. 280–291, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Zhang, J. Cao, Q. Weng et al., “Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) by tirapazamine is dependent on eiF2alpha phosphorylation rather than the mTORC1/4E-BP1 pathway,” PLoS ONE, vol. 5, no. 11, Article ID e13910, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. R. K. Jain, D. G. Duda, J. W. Clark, and J. S. Loeffler, “Lessons from phase III clinical trials on anti-VEGF therapy for cancer,” Nature Clinical Practice Oncology, vol. 3, no. 1, pp. 24–40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Hamatsu, T. Rikimaru, Y. Yamashita et al., “The role of MTA1 gene expression in human hepatocellular carcinoma,” Oncology Reports, vol. 10, no. 3, pp. 599–604, 2003. View at Google Scholar
  22. W. S. Moon, K. Chang, and A. S. Tarnawski, “Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: relationship to vascular invasion and estrogen receptor-α,” Human Pathology, vol. 35, no. 4, pp. 424–429, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Stengel, S. P. Newman, M. P. Leese et al., “The in vitro and in vivo activity of the microtubule disruptor STX140 is mediated by Hif-1 alpha and CAIX expression,” Anticancer Research, vol. 35, no. 10, pp. 5249–5262, 2015. View at Google Scholar · View at Scopus
  24. A. Zimna and M. Kurpisz, “Hypoxia-inducible factor-1 in physiological and pathophysiological angiogenesis: applications and therapies,” BioMed Research International, vol. 2015, Article ID 549412, 13 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. Y.-G. Yoo, G. Kong, and M.-O. Lee, “Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1α protein by recruiting histone deacetylase 1,” EMBO Journal, vol. 25, no. 6, pp. 1231–1241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Dhar, A. Kumar, L. Zhang et al., “Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer,” Oncotarget, vol. 7, no. 14, pp. 18469–18484, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Lu, C. Wei, and Z. Xi, “Curcumin suppresses proliferation and invasion in non-small cell lung cancer by modulation of MTA1-mediated Wnt/β-catenin pathway,” In Vitro Cellular and Developmental Biology—Animal, vol. 50, no. 9, pp. 840–850, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Kai, S. K. Samuel, and A. S. Levenson, “Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex,” International Journal of Cancer, vol. 126, no. 7, pp. 1538–1548, 2010. View at Publisher · View at Google Scholar · View at Scopus